20Jun
District of Delaware Grants Motions for Summary Judgment in Three Risperdal Gynecomastia Cases
In a trio of recent decisions arising out of cases alleging that an antipsychotic medication, Risperdal, and its generic, risperidone, had caused gynecomastia (breast tissue growth) in men, the United States District Court for the District of...
By:
Drinker Biddle & Reath LLP
Related
On July 9 and October 12, 2020, the Delaware Supreme Court added two more opinions to its growing su...
Read More >
The FTC and the DOJ Antitrust Division have again warned companies, along with their board members a...
Read More >
On 4 February 2021 the Federal Trade Commission (FTC) announced that U.S. antitrust agencies will te...
Read More >
In December, the National Labor Relations Board (NLRB) issued a flurry of employer-friendly decision...
Read More >
Earlier this year, Governor Newsom signed two amendments to SB 1343 extending the deadline to comply...
Read More >
On October 9, 2019, President Donald Trump announced his intention to appoint Amanda Wood Laihow to ...
Read More >